Business
    Next Score View the next score

    Mass. Movers

    Haemonetics earnings slide 46 percent

    Brian Concannon is the chief executive of Haemonetics.
    Yoon S. Byun/Globe Staff/File 2010
    Brian Concannon is the chief executive of Haemonetics.

    Haemonetics Corp. slid after it said quarterly earnings fell 46 percent. The Braintree company, which makes and sells blood-management systems, earned $9.9 million, or 19 cents per share, in the quarter ended in December, compared to $18.3 million, or 36 cents, a year earlier. Administrative and other expenses rose 41 percent; research and development costs rose about 15 percent. Haemonetics said it expects its new OrthoPat Advance system to drive fiscal 2014 growth.